American University of Beirut Medical Center

🇱🇧Lebanon

Country: 🇱🇧Lebanon

Ownership: Private

Established: 1902-01-01

Employees: -

Market Cap: -

Website: http://www.aubmc.org/pages/home.aspx

Clinical Trials

Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes

Phase 3

Completed

Conditions: Pregnancy Complications
Hypovitaminosis D
Infant, Newborn, Diseases

Interventions: Dietary Supplement: Euro D

First Posted Date: 2015-05-05

Last Posted Date: 2023-03-20

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 330

Registration Number: NCT02434380

Locations: 🇱🇧
American University of Beirut, Hamra, Lebanon

The Effectiveness of a Customized Mobile Application in Colonoscopy Preparation

Not Applicable

Completed

Conditions: Colonoscopy Preparation

Interventions: Other: Instruction leaflet
Other: Mobile App
Other: Explanation of paper and application instructions
Other: Picoprep solution

First Posted Date: 2015-04-08

Last Posted Date: 2015-12-29

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 160

Registration Number: NCT02410720

Locations: 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon

Effect of Uterine Massage Versus Sustained Uterine Compression on Blood Loss After Vaginal Delivery

Not Applicable

Completed

Conditions: Postpartum Hemorrhage

Interventions: Procedure: Uterine Massage
Procedure: Uterine Compression

First Posted Date: 2015-03-24

Last Posted Date: 2021-07-22

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 445

Registration Number: NCT02396771

Locations: 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon

"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"

Phase 4

Completed

Conditions: Anesthesia Recovery

Interventions: Drug: Sugammadex
Drug: Neostigmine
Drug: glycopyrrolate

First Posted Date: 2015-03-02

Last Posted Date: 2018-06-27

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 56

Registration Number: NCT02375217

Locations: 🇱🇧
AUBMC, Beirut, Lebanon

Effect of Phosphorus Supplementation on Body Weight

Not Applicable

Completed

Conditions: Body Weight

Interventions: Dietary Supplement: phosphorus

First Posted Date: 2015-01-01

Last Posted Date: 2016-01-08

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 71

Registration Number: NCT02329990

Lactose-free Milk in Infants With Acute Diarrhea in a Developing Country

Not Applicable

Terminated

Conditions: Acute Gastroenteritis

Interventions: Dietary Supplement: Lactose- free milk

First Posted Date: 2014-09-22

Last Posted Date: 2019-02-15

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 6

Registration Number: NCT02246010

Locations: 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon

Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery

Phase 2

Completed

Conditions: Obesity
Sleep Apnea
Hypertension
Diabetes

Interventions: Drug: Dexmedetomidine
Drug: Morphine

First Posted Date: 2014-08-11

Last Posted Date: 2016-07-13

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 60

Registration Number: NCT02213159

Locations: 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon

Ultrasound-Guided vs Landmark Technique for Femoral Arterial Cannulation in Pediatric Cardiac Surgery

Not Applicable

Completed

Conditions: Time Needed to Achieve a Successful Cannulation of the Femoral Artery in Pediatric Cardiac Surgery

Interventions: Other: Landmark
Device: Ultrasound

First Posted Date: 2014-07-08

Last Posted Date: 2017-01-26

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 106

Registration Number: NCT02183857

Locations: 🇱🇧
American University of Beirut Medical center, Beirut, Lebanon

Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting

Phase 4

Completed

Conditions: Postoperative Nausea and Vomiting

Interventions: Drug: 4 mg of Ondansetron IV
Drug: 1mg of Haloperidol IV

First Posted Date: 2014-05-21

Last Posted Date: 2014-05-22

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 120

Registration Number: NCT02143531

Locations: 🇱🇧
Marie Aouad, Beirut, Lebanon

Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia

Phase 4

Completed

Conditions: Anesthesia Recovery
Anesthesia Emergence
Shivering
Postoperative Recovery

Interventions: Drug: dexmedetomidine 0.25 µg/kg IV
Drug: dexmedetomidine 1 µg/kg IV
Drug: dexmedetomidine 0.5 µg/kg IV
Drug: Placebo Comparator

First Posted Date: 2014-05-19

Last Posted Date: 2018-06-27

Lead Sponsor: American University of Beirut Medical Center

Target Recruit Count: 216

Registration Number: NCT02141412

Locations: 🇱🇧
American University of Beirut Medical Center, Beirut, Lebanon

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy